Alveus Therapeutics
Philadelphia
About Alveus Therapeutics
Alveus Therapeutics is a clinical-stage biotech company developing therapies for obesity and metabolic diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $197.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2026)
- Website: alveustx.com
- Phone: [email protected]
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/alveus-therapeutics-5412 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.